11.2.8 Teva Pharmaceutical Industries Ltd.
11.2.9 Amgen Inc.
11.2.10 Biocon
12. Future Outlook
List of Tables:
Table 5-1: Global - Biosimilar EPOs Approved for Marketing
Table 5-2: Global - Biosimilar EPOs in Pipeline
Table 5-3: Global - Biosimilar HGH Approved for Marketing
Table 5-4: Global - Biosimilar HGH in Pipeline
Table 5-5: Global - Biosimilar G-CSF Approved for Marketing
Table 5-6: Global - Biosimilar G-CSF in Pipeline
Table 5-7: Global - Biosimilar mAbs Approved for Marketing
Table 5-8: Global - Biosimilar mAbs in Pipeline
Table 5-9: Global - Biosimilar Insulin Approved for Marketing
Table 5-10: Global - Biosimilar Insulin in Pipeline
Table 5-11: Global - Biosimilar Interferons Approved for Marketing
Table 5-12: Global - Biosimilar Interferons in Pipeline
Table 9-1: Global - Major M&A in the Biosimilar Industry (2014-2016)
Table 11-1: Biocad - Major Biosimilars Approved for Marketing
Table 11-2: Biocad - Major Biosimilars in Pipeline
Table 11-3: Celltrion Inc. - Revenue (Million US$), 2013, 2014 & 2015
Table 11-4: Celltrion Inc. - Major Biosimilars Approved for Marketing
Table 11-5: Celltrion Inc. - Major Biosimilars in Pipeline
Table 11-6: Dong-A Socio Group - Revenue (Million US$), 2013, 2014 & 2015
Table 11-7: Dong-A Socio Group - Major Biosimilars in Pipeline
Follow Us: